Dr Reddy’s Gets USFDA Tentative Nod for Generic Lenacapavir
Dr Reddy’s wins USFDA tentative approval under PEPFAR for generic twice-yearly lenacapavir for HIV prevention, with first supplies due before end-2026.
DR-REDDYS
Dr. Reddy’s Expands Partnership with Sanofi to Launch RSV Drug Beyfortus in India
Dr. Reddy’s Laboratories is set to expand its collaboration with Sanofi Healthcare India (SHIPL) by launching the novel drug Beyfortus […]
Dr Reddy’s CPS facility clears USFDA audit
Dr Reddy’s Laboratories has received establishment inspection report (EIR) from the US health regulator for a unit of its Srikakulam […]
Dr. Reddy’s Laboratories launches Omeprazole and sodium bicarbonate capsules in the US market
Dr. Reddys Laboratories Ltd, an integrated pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives, announced on […]
Promius Pharma receives FDA approval for Sernivo Spray
Dr Reddys US subsidiary, Promius Pharma has received theapproval for Sernivo (betamethasone dipropionate) Spray,0.05 per cent from the US Food […]
Biocodex Inks Distribution Pact with Dr Reddys
Dr Reddy’s Laboratories has entered into a strategic alliance with Biocodex to market and distribute Biocodex products in the Romanian […]
Dr Reddy’s Nise D spray Quick Pain Reliever
Pharma major Dr Reddy’s Laboratories announced the launch of Nise D spray, which offers quick and targeted pain killing. Strengthening […]
